William H. Warren, MD

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

1. Anterior mediastinal mass secondary to histoplasmosis.
   Shersher DD, Hong E, Breard J, Warren WH, Liptay MJ.
   Ann Thorac Surg. 2012
   2012 Jan
   93(1):e9-10. doi: 10.1016/j.athoracsur.2011.07.093.
   
2. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
   Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.
   Clin Lung Cancer. 2012
   2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print]
   
3. Biomarkers of the Insulin-Like Growth Factor Pathway Predict Progression and Outcome in Lung Cancer.
   Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA.
   Ann Thorac Surg.
   2011 Sep 24
   
4. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
   Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P.
   J Thorac Oncol.
   2011 Jun
   6(6):1079-86.
   
5. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
   Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP.
   Ann Thorac Surg.
   2011 Jul
   92(1):233-41; discussion 241-3
   
6. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
   Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ
   Lung Cancer
   2011 Feb
   71(2):186-90
   
7. Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis.
   Shersher DD, Hong E, Warren W, Penfield Faber L, Liptay MJ.
   Ann Thorac Surg.
   2011 Dec
   92(6):e113-4.
   
8. Weight Gain in Advanced Non-Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy is Associated With Superior Survival
   Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP
   Int J Radiat Oncol Biol Phys
   2010 Oct 5
   
9. A multi-analyte serum test for the detection of non-small cell lung cancer
   Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, Warren WH, Bonomi P, Liptay MJ, Borgia JA
   Br J Cancer
   2010 Oct 12
   103(8):1221-8
   
10. Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival
    Kim AW, Faber LP, Warren WH, Shah ND, Basu S, Liptay MJ
    J Thorac Cardiovasc Surg
    2010 Mar
    139(3):606-11
    
11. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy
    Hollings DD, Higgins RS, Faber LP, Warren WH, Liptay MJ, Basu S, Kim AW
    Am J Surg
    2010 Apr
    199(4):558-61
    
12. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP
    Ann Thorac Surg
    2009 Sep
    88(3):945-50; discussion 950-1
    
13. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW, Faber LP, Warren WH, Basu S, Wightman SC, Weber JA, Bonomi P, Liptay MJ
    Ann Thorac Surg
    2009 Sep
    88(3):937-43; discussion 944
    
14. An unusual case of Aspergillus fibrosing mediastinitis
    Wightman SC, Kim AW, Proia LA, Faber LP, Gattuso P, Warren WH, Liptay MJ
    Ann Thorac Surg
    2009 Oct
    88(4):1352-4
    
15. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer
    Borgia JA, Basu S, Faber LP, Kim AW, Coon JS, Kaiser-Walters KA, Fhied C, Thomas S, Rouhi O, Warren WH, Bonomi P, Liptay MJ
    J Thorac Oncol
    2009 Mar
    4(3):338-47
    
16. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer
    Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, Hammoud ZT, Kim AW
    J Surg Oncol
    2009 Dec 15
    100(8):703-7
    
17. Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies
    Kim AW, Liptay MJ, Saclarides TJ, Warren WH
    Interact Cardiovasc Thorac Surg
    2009 Aug
    9(2):379-81
    
18. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial
    Kim AW, Faber LP, Warren WH, Saclarides TJ, Carhill AA, Basu S, Choh MS, Liptay MJ
    Surgery
    2008 Oct
    144(4):712-7; discussion 717-8
    
19. Management of malignant pleural effusions using the Pleur(x) catheter
    Warren WH, Kalimi R, Khodadadian LM, Kim AW
    Ann Thorac Surg
    2008 Mar
    85(3):1049-55
    
20. Utility of silicone esophageal bypass stents in the management of delayed complex esophageal disruptions
    Kim AW, Liptay MJ, Snow N, Donahue P, Warren WH
    Ann Thorac Surg
    2008 Jun
    85(6):1962-7; discussion 1967
    
21. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion
    Warren WH, Kim AW, Liptay MJ
    Eur J Cardiothorac Surg
    2008 Jan
    33(1):89-94
    

• To watch a brief video of William H. Warren, MD, click the play button at the lower left corner of the video frame below.
• (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
• View Transcript

• We perform the entire gamut of general thoracic surgery, including chest wall surgery, the entire scope of esophageal surgery, in addition to operating on the lungs.
  
  We now operate through much smaller incisions so patients have less post-operative pain. They go home, on the average, a day earlier than they would have with the other procedure. But more importantly I think that they end up having less post-operative pain when they do go home — and they can return to their regular activities much faster than they could before.
  
  I encourage patients to use the Internet, and I encourage patients to get second opinions and become educated about their condition. But, it’s surprising how many patients can get misinformation from the Internet, and I think it’s really important that they talk with their doctors — referring doctors and other doctors that they have seen — regarding their condition.